Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |